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INTRODUCTION
“For all the happiness mankind can gain is not in
pleasure but in rest from pain”
—John Dryden
Spinal anaesthesia is widely used for surgeries involving the lower limb, 
perineum and inguinal region. The duration of spinal anaesthesia that is timed 
according to the duration of surgery may help prevent complications associated 
with prolonged immobilization especially in elderly patients.
Recently  there  has  been  an  interest  in  using  analgesics  and  local 
anaesthetics in an attempt to decrease the local anaesthetic dose enabling faster 
recovery  while  improving  anaesthetic  success  and  providing  effective  post 
operative analgesia. The use of intrathecal lignocaine for spinal anaesthesia has 
been questioned because of the frequent occurrence of Transient Neurological 
Symptoms.  An  increasing  number  of  surgeries  being  performed  in  the 
ambulatory setting under spinal anaesthesia has generated interest in finding 
alternative  drugs  that  would  provide  adequate  surgical  anaesthesia  while 
having quick recovery profile and low side effect profile.
The  discovery  of  opioid  receptors  has  opened  new horizons  in  pain 
management.  Since  their  introduction  into  clinical  practice  in  1979,  spinal 
opioids  have  achieved great  international  popularity  in  a  variety  of  clinical 
settings either as sole analgesic agents or in combination with low-dose local 
anesthetic agents. By bypassing blood and the blood-brain barrier, small doses 
of opioids administered in either the subarachnoid or epidural spaces provide 
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profound and prolonged segmental analgesia.  Numerous studies have shown 
that  spinal  opioids  can  provide  profound  postoperative  analgesia  with  less 
central  and  systemic  adverse  effects  than  can  opioids  administered 
systematically. Several reviews have appeared in the literature.
The rationale for  the combination technique is  that  opioids and local 
agents eliminate pain by acting at two distinct sites—the local anaesthetic at the 
nerve axon and the opioid at the receptor site in the spinal cord. If even an 
extremely low concentration of local anaesthetic is added to the opioid, the 
quality of analgesia may be far superior. This study thus was designed to test 
the hypothesis that adding an opioid to the local anaesthetic in the subarachnoid 
space provides great advantages as has been reported extensively in literature.
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AIM OF THE STUDY
To study the effect of
Low dose Hyperbaric Bupivacaine 10 mg
with 5 μg of Sufentanil
Vs.
Low dose Hyperbaric Bupivacaine 10 mg
with 50 μg of Fentanyl
on
1. Block characteristics
2. Hemodynamic changes 
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SPINAL ANAESTHESIA
Spinal  (subarachnoid/intrathecal)  anaesthesia  is  a  form  of  central 
neuraxial  block  in  which  a  temporary  interruption  of  nerve  transmission  is 
achieved following injection of local anaesthetic and/or adjuvant solutions into 
the subarachnoid space.
Spinal anaesthesia is one of the most frequently employed methods of 
regional anaesthesia.
Anatomy
The vertebral  canal  extends  from the  foramen magnum to the  sacral 
hiatus.  It  is  formed by the dorsal  spine, pedicles and laminae of successive 
vertebrae (7 cervical, 12 thoracic, 5 lumbar and 5 sacral). The vertebrae are 
held  together  by  a  series  of  overlapping  ligaments  namely  anterior  and 
posterior  longitudinal  ligaments,  ligamentum flavum,  interspinous  ligament, 
supraspinous ligament and the intervertebral discs.
The spinal cord, a direct continuation of the medulla oblongata begins at 
the upper border of the atlas and terminates distally in the conus medullaris. 
The distal  termination,  because  of  the  differential  growth rates  between the 
bony vertebral canal and central nervous system varies from L3 in the infant, to 
the lower border of L1 in the adult.
Surrounding  the  spinal  cord  in  the  bony  vertebral  column  are  three 
membranes (from within to the periphery); the pia mater, arachnoid mater and 
dura mater. The pia mater is a highly vascular membrane that closely invests 
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the  spinal  cord.  The  arachnoid  mater  is  a  delicate  nonvascular  membrance 
closely  attached  to  the  outermost  dura  mater.  Between  the  two  innermost 
membranes is the subarachnoid space. In this space are the cerebrospinal fluid 
(CSF),  spinal  nerves,  blood vessels  that  supply  the  spinal  cord  the  dentate 
ligaments. Although the spinal cord ends at the lower border of L1 in adults, 
the  subarachnoid  space continues  to  S2.  The outer  membrane  in  the  spinal 
canal  is  the longitudinally organized fibroelastic membrane, the dura mater. 
This layer is the direct extension of the cranial dura mater and extends as the 
spinal dura mater from the foramen magnum to S2, where the filum terminale 
(an extension of the pia mater beginning at the conus medullaris) blends with 
the periosteum of the coccyx. There is a potential space between the dura mater 
and arachnoid, the subdural space which contains only small amounts of serous 
fluid to allow the dura and arachnoid move over each other. Surrounding the 
dura mater is the epidural space which extends from the foramen magnum to 
the  sacral  hiatus.  Posterior  to  the  epidural  space  is  the  ligamentum flavum 
which extends  from the foramen magnum to the sacral  hiatus.  Immediately 
posterior  to  the  ligamentum flavum is  the  interspinous  ligament,  extending 
from  the  external  occipital  protuberance  to  the  coccyx,  posterior  to  these 
structures is the supraspinous ligament.
Lumbar puncture is routinely done below the L2 vertebra down to the 
L5-S1 interspace to avoid damaging the spinal cord which ends at the lower 
border of L1 vertebra in adults.
Physiology of Subarachnoid Block Cerebrospinal Fluid
The cerebrospinal fluid (CSF) is an ultrafiltrate of blood plasma with 
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which it is in hydrostatic and osmotic equilibrium. It is a clear, colourless fluid 
found in the spinal and cranial subarachnoid space and in the ventricles of the 
brain. The average volume in the adult ranges from 120-150ml of which 35ml 
is in the ventricles, 25ml is in the cerebral subarachnoid space and 75 ml is in 
the spinal subarachnoid space. It is secreted by the choroids plexus at a rate of 
0.3 – 0.4 ml/minute.
Physical characteristics of Cerebrospinal Fluid
pH 7.4
Specific gravity referred to H2O
at body temperature .007
at 40C .0003
Density 1.0003 g/ml
Baricity 1.000
Pressure 8-12mm Hg/70-80mm H20
Cells 3-5/cu.mm
Proteins 20 mg/dl
Glucose 45-80 mg/dl
The cerebrospinal fluid plays an important role in spinal anaesthesia as 
media  for  dispersion  of  the  local  anaesthetic  drug  to  the  spinal  nerve.  An 
important factor determining the spread of drugs in the subarachnoid space is 
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the specific gravity of the injected solution compared with that of CSF. 
Mechanics of Spinal Anaesthesia
Injection of local anaesthetics into the spinal CSF allows access to sites 
of action both within the spinal cord and the peripheral nerve roots. The nerve 
roots leaving the spinal canal are not covered by epineurium and are readily 
exposed to the local  anaesthetic within the CSF.Therefore afferent impulses 
entering  the  central  nervous  system via  the  dorsal  nerve  roots  and  efferent 
impulses  leaving  via  the  ventral  nerve  roots  are  blocked  during  spinal 
anaesthesia.  Spinal  local  anaesthetics  block  sodium channels  and  electrical 
conduction in spinal nerve roots. Local anaesthetics can exert sodium channel 
block  within  the  dorsal  and  ventral  horns,  inhibiting  generation  and 
propagation  of  electricity  activity.  The  order  in  which  the  nerve  fibres  are 
blocked in-spinal anaesthesia is preganglionic sympathetic B fibres followed 
by temperature fibres (cold before warmth), fibres carrying pin-prick sensation, 
touch,  deep  pressure,  somatic  motor  sensation  and  lastly  fibres  conveying 
vibration sense and priprioceptive impulses. Recovery is roughly in the reverse 
order.
Spread of Local Anaesthetics in Subrachnoid Space
The  local  anaesthetic  solution  is  diluted  by  CSF  and  therefore  its 
original  concentration  is  of  less  importance  than  the  actual  mass  of  drug 
injected.  Spread is  also determined by  the  baricity  of  the  injected solution. 
Baricity is a ratio comparing the density of a local anaesthetic solution at a 
specified  temperature  to  the  density  of  CSF  at  the  same  temperature.  A 
hypobaric solution has a baricity less than 1.0000 or specific gravity less than 
1.0069 (the mean value of CSF specific gravity). A hyperbaric solution has a 
baricity greater than 1.0000 or specific gravity more than 1.0069. Hypobaric 
and hyperbaric solutions are prepared from isobaric solutions by addition of 
various amounts of sterile distilled water and dextrose respectively. Isobaric 
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solutions do not move under  the influence of  gravity  in the CSF,  therefore 
spread of isobaric solutions and consequently height of block is not influenced 
by  position  of  patient  and  is  somewhat  and  is  unpredictable.  Hyperbaric 
solutions, being heavier than CSF, settle to the most dependent aspect of the 
subarachnoid  space,  which  is  determined  by  the  position  of  the  patient.  In 
supine  patients,  hyperbaric  solutions  gravitate  to  the  thoracic  kyphosis  and 
Hypobaric solution float’s up.
The major factors affecting height of subarachnoid block are the baricity 
of the local anaesthetic solution and the dosage (mass) of drug injected.
Fate of Local Anaesthetics in the Subarachnoid Space
Following  injection  of  local  anaesthetic  solution  into  subarachnoid 
space, its concentration falls rapidly. The initial steep fall is due to mixing with 
CSF and subsequent absorption into nerve roots and spinal cord. The egress of 
local  anaesthetics  following subarachnoid  injection  is  primarily  by  vascular 
absorption  with  no  hydrolysis  or  degradation  taking  place  in  the  CSF. 
Depending  on  the  type  of  drug  used,  it  is  metabolized  in  plasma  by 
pseudocholinesterase or in the liver.  As duration of anaesthesia is in part,  a 
result of the rate of absorption from the subarachnoid space, the addition of a 
vasconconstrictor to the local anaesthetic solution will retard absorption of the 
drug and thus increase the duration of anaesthesia.
Indications for Subarachnoid Block
Spinal anaesthesia can be administered whenever a surgical procedure 
can be done with a sensory level of anaesthesia that does not produce adverse 
patient outcome. Such procedures include:
• Lower abdominal surgeries
• Lower limb surgeries
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• Urological procedures
• Gynecological surgeries
• Perineal and rectal surgeries
Contraindications for Subarachnoid Block
An absolute contraindication for subarachnoid block is patient refusal.
Other contraindications are:
• Local sepsis
• Uncorrected coagulopathy
• uncontrolled blood loss / shock
• fixed cardiac output states
• documented allergy to local anaesthetics
• raised intracranial pressure
• neurological disease
• major spine deformities/previous surgery on the spine
• severe cardiac disease
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METHODS OF PAIN MEASUREMENT
Pain is a personal, subjective experience influenced by cultural learning, 
the meaning of the situation, attention and other psychological variables. 
Melzack30 suggested a three dimensional view of pain which comprises 
of  sensory-discriminative,  motivational-affective,  cognitive–evaluative 
components.
Methods of Pain Measurement include
1. Verbal rating scale
2. Visual analogue pain scale
3. . Mc Gill pain Questionnaire
4. . The Descriptor Differential Scale
Visual Analogue Pain Scale
Advantages
1. Simple, efficient, minimally intrusive measure of pain intensity
2. Widely used in clinical as well as research settings
3. Provided  that  adequate  clear  instructions  are  given  to  the  patient,  its 
conceptual simplicity.
Disadvantages
1. Bias of expectancy for change and reliance on memory
2 It is assumption that pain is a unidimensional experience
10
INTRATHECAL OPIOIDS
History
Opiate receptors were first identified in the central nervous system in 
1973 by  Pert CB and Snyder SH34. Subsequently, large populations of these 
receptors were localized in the dorsal horn of the spinal cord. In 1976, Yaksh 
TL and Rudy TA49 performed animal studies and demonstrated the ability of 
intrathecal  opioids  to  produce  analgesia.  In  1979,  Wang45 and  colleagues 
reported pain relief using intrathecal morphine in cancer patients and in the 
same year,  Behar et al.4 achieved the same result injecting the drug into the 
epidural space.
Neuraxial opioids
Placement of opioids in the epidural or sub arachnoid space to manage 
acute  or  chronic  pain  is  based  on  the  knowledge  that  opioid  receptors 
[principally mu receptors] are present in the substantia gelatinosa of the spinal 
cord [Cousins and Mather,8 1984]. Analgesia produced by neuraxial opioids, 
in contrast to intravenous [IV] administration of opioids or regional anaesthesia 
with  local  anaesthetics,  is  not  associated  with  sympathetic  nervous  system 
denervation, skeletal muscle weakness, or loss of proprioception. Analgesia is 
dose related.
Spinal opioid receptors – location
Opioid receptors are synthesized in the cell body of the sensory neuron 
and are transported in both the central and peripheral directions. In the spinal 
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cord, opioid receptors are found in the dorsal horn in the terminal zones of C 
fibers primarily in laimna I of the substantia gelatinosa. Spinal opioid receptors 
are 70% mu, 24% delta and 6% kappa.
Mechanism of Action
Opioids act as agonists at stereospecific opioid receptors at pre synaptic 
and post synaptic sites in the central nervous system (principally the brain and 
spinal cord) and outside the CNS, in peripheral tissues.
The  principal  effect  of  opioid  receptor  activation  is  a  decrease  in 
neurotransmission by presynaptic inhibition of neurotransmitter (acetylcholine, 
dopamine,  norepinephrine,  substance  P)  release,  although  post  synaptic 
inhibition  of  evoked  activity  also  occur.  The  biochemical  events  following 
opioid  receptor  activation  are  characterized  by  increased  potassium 
conductance  (leading  to  hyperepolarisation),  calcium channel  activation,  or 
both, which produced an immediate decrease in neurotransmitter release.
Activation  of  opioid  receptors  in  the  primary  afferent  neurons  may 
either directly decrease neurotransmission or inhibit the release of excitatory 
neurotransmitters such as substance P.
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Opioid Receptors
Mu1 Mu2 Kappa Delta
Effect Analgesia
(supra  spinal
and spinal)
Euphoria
Low  abuse 
potential 
Miosis
Bradycardia
Hypothermia
Urinary 
retension
Analgesia 
(Spinal)
Depression of 
Ventilation
Physical 
dependence
Constipation 
(marked)
Analgesia 
(Supraspinal 
and spinal)
Dysphoria 
Sedation
Low  abuse 
potential 
Miosis
Diuresis
Analgesia
(supraspinal 
and spinal)
Depression of 
ventilation 
Physical 
dependence
Constipation 
(minimal) 
Urinary 
retension
Agonists Endorphins
Morphine
Synthesic 
opioids
Endorphins
Morphine
Synthesic 
opioids
Dynorphine Enkephalins
Antagonists Naloxone
Naltrexone
Nalmefene
Naloxone
Naltrexone
Nalmefene
Naloxone
Naltrexone
Nalmefene
Naloxone
Naltrexone
Nalmefene
Neuraxial Opioids
Based on the knowledge that opioid receptors (principally mu receptors) 
are present in the substantia gelatinosa of the spinal cord.
In  contrast  to  intravenous  administration  of  opioids  (or)  regional 
anaesthesia with local anaesthetics, analgesia produced by neuraxial opioids is 
not associated with sympathetic nervous system denervation, skeletal muscle 
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weakness or loss of proprioception. Analgesia is dose related and is specific for 
visceral  rather  than  somatic  pain  and  it  decreases  the  minimum  alveolar 
concentration (MAC) of the volatile anaesthetics.
Spinal Opioid Receptors – Location
Opioid receptors are synthesized in the cell body of the sensory neuron 
and are transported in both the central and peripheral directions. In the spinal 
cord, opioid receptors are found in the dorsal horn in the terminal zones of C 
fibers primarily in lamina I of the substantia gelatinosa. Spinal opioid receptors 
are 70% mu, 24% delta and 6% kappa.
Mechanism of Action
Spinal  opioids  act  at  nerve  synapses  either  presynaptically  [as 
neuromodulators]  or  postsynaptically  [as  neurotransmitter].  Stimulation  of 
presynaptic receptors is associated with hyperpolarization of the terminal and 
reduced substance  P  release.  This  relates  primarily  to  inhibition  of  voltage 
gated  calcium  channels.  Postsynaptic  membrances  contain  opioid  receptors 
linked to potassium channels. Stimulation of these receptors enhances outward 
flow of potassium thereby stabilizing the membrane, making it less sensitive to 
neurotransmitters.  These  actions  are  carried  out  by  second  messengers  [G 
proteins].
With  the  injection  of  an opioid  into the  CSF,  a  reservoir  of  drug is 
created that passively diffuses into the dorsal horn of the spinal cord where it 
exerts its action by binding to opioid receptors.
Pharmacokinetics
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The onset of analgesic effect following intrathecal administration of an 
opioid is directly proportional to the lipid solubility of the drug, whereas the 
duration of effect is longer with more hydrophilic compounds. Opioids placed 
in the epidural space undergo significant systemic absorption and passage into 
the subarachnoid space. Vascular absorption after intrathecal administration of 
opioids is insignificant. Cephalad movement of opioids in the CSF is dependent 
on  lipid  solubility.  Lipid  soluble  opioids  like  fentanyl  are  limited  in  the 
cephalad migration by uptake into the spinal cord, while hydrophilic opioids 
like morphine remain in the CSF for transfer to more cephalad locations.
Loss  of  analgesia  after  intraspinal  injection  primarily  results  from 
clearance of drug from the site of action. Intrathecal opioids are eliminated by 
diffusion along the neuraxis and vascular absorption. It is not yet established 
what role metabolism plays in the termination of action of intrathecal opioids.
Tolerance
Decrease  in  effect  over  time  to  a  given  dose  of  drugs  has  been 
demonstrated with intrathecal opioids. There is good evidence in support of the 
glutatmate receptor of the NMDA type to be involved in the mechanism of 
tolerance.
Benefits
• Long lasting post operative analgesia after a single injection
• Precise and reliable placement of low concentration of drug near its site of 
action.
The principle disadvantage is its  lack of titrability and need to either 
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repeat the injection or consider other options when the analgesic effect of the 
initial dose wanes. Nevertheless, it is common clinical experience that after the 
analgesic  effect  of  the  initial  intrathecal  dose  wanes,  the  intensity  of  post 
operative pain is greatly diminished and can be satisfactorily managed by other 
modalities.
Side Effects
1. Pruritus
Pruritus  is  the  most  common  side  effect  and  is  more  likely  to  be 
localized  to  the  face,  neck  or  upper  thorax,  often  elicited  only  after  direct 
questioning, particularly in obstetric patients, due to the interaction of estrogen 
with opioid receptors. It is due to cephalad migration of the opioid in CSF and 
subsequent  interaction  with  opioid  receptors  in  the  trigeminal  nucleus. 
Naloxone, an opioid antagonist is effective in relieving pruritus.
2. Urinary Retention
More common in young males and with epidural  administration than 
after IM or IV administration.
It is most likely due to interaction with opioid receptors located in sacral 
segment of the spinal cord and inhibition of sacral parasympathetic nervous 
system  outflow,  which  causes  detrusor  muscle  relaxation  and  increase  in 
bladder  capacity,  leading  to  urinary  retention  and  is  readily  reversed  with 
Naloxone.
3. Depression of ventilation
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This  is  the  most  serious  side  effect  of  neuraxial  opioids  which  may 
occur within one minute or may be delayed for hours, requiring intervention.
Early  depression  of  ventilation  occurs  within  2  hours  of  neuraxial 
injection of opioid and results from systemic absorption of the lipid soluble 
opioids. Eg. Fentanyl, Sufentanil.
Delayed depression of ventilation occurs more than 2 hours and reflects 
cephalad migration of the opioid in the CSF and subsequent interaction with 
the opioid receptors in the ventral medulla. Eg. Morphine.
Factors that increase the risk of depression of ventilation.
High opioid dose
Low lipid solubility of opioids
Concomitant administration of parenteral opioids
Lack of opioid tolerance
Advanced age
4. Sedation – Dose related particularly with Sufentanil.
5. CNS excitation
Tonic  skeletal  muscle  rigidity  resembling  seizure  activity  occur 
following large IV doses of opioids but rarely with neuraxial administration. 
Cephald migration in the CSF and interaction with non-opioid receptors in the 
brain stem (or) basal ganglia is the most likely explanation, inhibition of the 
inhibitory neurotransmitters.
6. Viral reactivation
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Reactivation  of  herpes  simplex  labialis  may  occur  2  –  5  days  after 
epidural administration.
7. Neurotoxicity
Animal  and human studies have not demonstrated neurotoxicity  with 
any of the commercially available preservative free opioid agents administered 
by the subarachnoid route. 
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PHARMACOLOGY OF BUPIVACAINE
Bupivacaine is an amide local anaeshetic, synthesized by A.F. Ekenstam 
in 1957 and brought into clinical use in 1963.
It  is  produced for clinical use in a racemic mixture,  containing equal 
proportions of the ‘S’ and ‘R’ enantiomers. It is supplied for clinical use as a 
hydrochloride salt.
Chemical Structure
Description:  1–  Butyl-N-(2,6-dimethylphenyl)-2-piperidine  Decarboxamide 
Hydrochloride monohydrate
Physico-Chemical Profile
Molecular Weight (base) 288
pKa 8.1
Solubility in 
Alcohol 1 in 8
Water 1 in 25
Octanol/water partition 
coefficient High
19
Lipid solubility 28
Plasma Protein Binding 95%
Mechanism of Action
Bupivacaine exerts its effect by inhibition of sodium channels. It acts to 
block conduction in the nerves by decreasing or preventing the large transient 
increases in permeability of  the cell  membrane to  sodium ions that  follows 
depolarization of the membrane. Bupivacaine also reduces the permeability of 
the resting nerve membrane to potassium as well as sodium ions.
Pharmacodynamics
Bupivacaine by virtue of its pharmacological effects, has a stabilizing 
action on all excitable membranes. In the central nervous system, stimulation 
can  occur  producing  restlessness,  tremors  and  convulsions  in  over  dosage. 
Bupivacaine also causes a reduction of automaticity in the heart.
The clinical profile of nerve blockade produced by Bupivacaine differs 
from that of Lignocane. It is 4 times more potent than Lignocaine, but the onset 
of action is slower. The duration of action is considerably longer. The sensory 
block produced by Bupivacaine tends to be more marked than the motor block.
Pharmacokinetics
Bupivacaine is rapidly absorbed from the site of injection. The rate of 
rise in plasma Bupivacaine concentration and the peak plasma concentrations 
obtained  depend  on  the  route  of  administration.  There  is  also  some  inter-
individual variation and peak systemic concentrations may occur between 5 
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and 30 minutes after administration. The addition of a vasoconstrictor delays 
absorption and results in lower plasma concentrations of Bupivacaine. 
Pharmacokinetic Profile
Volume of distribution at steady state (Vdss) 72 litres
Clearance 0.47 l/mm
t ½ α 2.7 mm
t ½ β  28 mm
t ½ γ 3.5 hrs
Metabolism
Possible  pathways  for  metabolism  of  Bupivacaine  include  aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and conjugation. Only the N 
dealkylated metabolite, N-desmethylbupivacaine has been measured in blood 
and  urine  after  epidural  and  spinal  administration.  The  degradation  of 
Bupivacaine  takes  place  in  the  liver.  Renal  disease  is  unlikely  to  alter  the 
kinetics  of  Bupivacaine  to  any  great  extent.  Less  than  10% of  the  drug  is 
excrete unchanged in urine.
The  onset  of  action  of  Bupivacaine  occurs  20-30  minutes  after 
peripheral nerve block and duration lasts for 8-9 hours.
Clinical Applications
• Infiltration anaesthesia
• Peripheral nerve blocks
• Central neuraxial blocks (intrathecal, epidural and caudal)
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Contraindications
• Paracervical block (in obstetrics)
• Known hypersensitivity to amide local anaesthetics
• Intravenous regional anaesthesia (IVRA)
Preparations Available
0.25%, 0.5% solutions in 10 ml and 20 ml vials.
5mg/ml (0.5%) Bupivacaine and 80 mg dextrose in 4 ml ampoules for 
intrathecal injection (Baricity 1.027).
Recommended safe dose
Concentration used Maximum permitted dose
0.125% - 0.5% 2mg/kg body weight
0.75% (not to be used in obstetric 
epidurals)
Max.  over  4  hours  –  150  mg
Max. during 24 hours – 400 mg
0.5%  plain  /  hyperbaric  solution 
(intrathecal use)
20 mg
Adverse Reactions
Adverse reactions are associated mainly with excess plasma levels of the 
drug, which may be due to over dosage, unintentional intravascular injection or 
slow metabolic degradation.
CNS Reactions
Excitation  characterized  by  restlessness,  anxiety,  dizziness,  tinnitus, 
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blurred vision or tremors were possible proceeding to convulsions, followed by 
drowsiness, unconsciousness and cardiac arrest.
Cardiovascular System Effects
Bupivacaine  appears  to  be  more  cardiotoxic  than  Lidocaine  and this 
relates to the action of Bupivacaine on cardiac sodium channels (fast in, slow 
out agent) and physico-chemical properties like high lipid solubility and high 
protein  binding,  particularly  at  low pH.  Accidental  intravenous injection  of 
Bupivacaine  causes  dysrhythmias,  atrioventricular  block,  ventricular 
tachycardia and ventricular fibrillation. Pregnancy increases the sensitivity to 
cardiotoxic effects of Bupivacaine. 
Allergic Reactions
Manifests  as  urticaria,  pruritis,  angioneurotic  edema  etc.  Cross 
sensitivity among members of amide type local anaesthetics has been reported.
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PHARMACOLOGY OF FENTANYL
Fentanyl is a Phenylpiperidine – derivative, synthetic opioid agonist that 
is structurally related to Meperidine. As an analgesic, Fentanyl is 75 to 125 
times more potent than Morphine.
Chemical structure
Pharmacokinetics and physico-chemical properties
Fentanyl  has  a  more  rapid  onset  and  shorter  duration  of  action  than 
Morphine.  Effect  – Site  equilibration time between blood and the  brain for 
Fentanyl is 6.4 min. The greater potency and more rapid onset of action reflects 
the greater lipid solubility of Fentanyl compared with that of Morphine. Short 
duration of action of a single dose reflects its rapid redistribution to inactive 
tissues  such  as  fat,  skeletal  muscle  and  lungs.  Duration  of  analgesia  is 
prolonged following multiple IV doses or following continuous infusion.
pKa – 8.4
% Un ionized at pH 7.4 - < 10
Octanol / water partition coefficient – 813
% Bound to plasma protein – 84
24
Diffusible fraction (%) – 1.5
t ½ α, (min) 1 – 2
t ½ β, (min) 10 – 30
t ½ γ, (h) 2 – 4
Vde (L/kg)  0.4 – 1.0
Vdss (L/kg)  3 – 5
Clearance (ml/kg/mt) 10 – 20
Hepatic extraction ratio 0.8 – 1.0
Metabolism
Fentanyl  is  extensively metabolized by N – demethylation producing 
Norfentanyl, which is structurally similar to Normeperidine. It is excreted by 
the kidneys and can be detected in the urine for 72 hours after a single IV dose 
of Fentanyl.40
Routes of Administration
Oral,  parenteral  (IV  /  IM),  transmucosal  transdermal,  neuraxial 
(subarachnoid / epidural).
Clinical Uses
Intravenous Fentanyl
o Low doses of Fentanyl 1 to 2 μgm/kg IV, are injected to provide analgesia.
o Fentanyl  2  to  20  μgm/kg  IV,  administered  as  an  adjuvant  to  inhaled 
anaesthetics  in  an  attempt  to  blunt  circulatory  responses  to,Direct 
laryngoscopy for intubation of trachea
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• Sudden changes in the level of surgical stimulation
• Large doses of Fentanyl, 50 to 150 μgm/kg IV, have been used alone 
to  produce  surgical  anaesthesia.  It  has  the  advantage  of  stable 
haemodynamics due to the (a) lack of direct myocardial depressant 
effect, (b) absence of histamine release, and (c) suppression of stress 
responses to surgery.
Disadvantages
(a) Failure to prevent sympathetic nervous system responses to painful surgical 
stimulation at any dose, (b) possible patient awareness,  (c) postoperative 
depression of ventilation.
Transmucosal Fentanyl
Administered  as  a  transmucosal  preparation  in  a  delivery  device 
(lozenge mounted on a handle) designed to deliver 5 to 20 μg/kg of Fentanyl to 
decrease  preoperative  anxiety  and  to  facilitate  induction  of  anaesthesia, 
especially in children.
In  children  2  to  8  years  of  age,  preoperative  administration  of  oral 
Transmucosal Fentanyl, 15 to 20 μgm/kg 45 minutes before the induction of 
anaesthesia, reliably induces preoperative sedation and facilitate induction of 
inhalation anaesthesia.
Transdermal Fentanyl
Preparations delivering 75 to 100 μgm/hr result in peak plasma Fentanyl 
concentrations in about 18 hours that tend to remain stable during the presence 
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of the patch, followed by a decreasing plasma concentration for several hours 
after the removal of the delivering system, reflecting continued absorption from 
the cutaneous depot.  Transdermal system decrease the amount of parenteral 
opioids required for postoperative analgesia.
Side Effects:
Respiratory system: Persistent or recurrent depression of ventilation is a 
potential postoperative problem. Secondary peaks in plasma concentrations of 
Fentanyl from sequesterated sites have been attributed.
Cardiovascular system: Markedly depresses carotid sinus baroreceptor 
reflex control of heart rate in neonate with 10 μgm/kg IV. Care should be taken 
in neonates because cardiac output is primarily heart rate dependent.
Seizure activity following rapid administration
Changes in somatosensory evoked potentials and electroencephalogram 
with doses > 30 μgm/kg IV.
Intracranial Pressure – modest increase (6 to 9 mm Hg) in ICP despite 
maintenance of an unchanged PaCo2 in head injury patients accompanied by 
decrease in mean arterial pressure and cerebral perfusion pressure.
Drug Interactions
Potentiates  the  effect  of  Midazolam and decrease  the  dose  requirements  of 
Propofol.  The  Opioid  –  Benzodiazepine  combination  displays  marked 
synergism with respect to hypnosis and depression of ventilation.
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PHARMACOLOGY OF SUFENTANIL
Sufentanil is a semisynthetic thienyl analogue fentanyl with analgesic 
potency 5 to 10 times more than that of fentanyl. 
Structure / Chemistry
Pharmacological properties
Sufentanil’s  greater potency when compared to fentanyl is  due to its 
greater affinity for opioid receptors. EC50 (plasma concentration necessary to 
cause  50%  of  maximum  slowing  of  EEG)  is  12  times  more  potent  than 
fentanyl. An important distinction from fentanyl 1000-fold difference analgesic 
dose  of  sufentanil  and  the  dose  that  produces  seizures  in  animals.  This 
difference is 160-fold for fentanyl and may be important when large doses are 
used to produce anaesthesia. 
Pharmacokinetics
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The elimination half-time of sufentanil is intermediate between that of 
fentanyl  and  alfentanyl  (2.2  to  4.6  hours).  A  single  IV  dose  has  a  similar 
elimination half-time in patients with or without cirrhosis of liver. The volume 
of  distribution  and elimination half-time of  sufentanil  is  increased in  obese 
patients reflecting the high degree of liquid solubility of this drug.41 The high 
tissue  affinity  is  consistent  with  the  lipophilic  nature  of  sufentanil  which 
permits rapid penetration of the blood brain barrier and onset of CNS effects 
(effect site equilibration time of 6.2 minutes similar to that of 6.8 minutes for 
fentanyl). Cumulation occurs with the large doses. It undergoes significant first 
pass pulmonary uptake (approximately 60 per cent). Extensive protein binding 
(92.5%)  compared  to  that  of  fentanyl  (79  to  87%)  contributes  to  smaller 
volume of distribution characteristic of sufentanil. It is predominantly bound to 
alpha 1 acid glycoprotein whose levels are increased after surgery.6 Low levels 
of this protein in the pediatric age-group accounts for more free fraction of the 
drug resulting in a greater incidence of respiratory depression.
pk 8.0
% non-ionised (pH 7.4) 20
Protein binding (%) 93
Clearance (ml per minute) 900
Volume of distribution (litres) 123
Partition co-efficient 1727
Elimination half-time (hours) 2.2 to 4.6
Context sensitive half-time: 4 hours infusion (in minutes) 30
Efflect-site (blood brain) equilibration (in minutes) 6.2
Metabolism
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It  is  rapidly  metabolized  N-dealkalyation  and  O-demethylation.  O-
demethylated  product  dis  methyl  sufentanil  has  a  good  10%  activity  of 
sufentanil less than 1% of the administered drug appears unchanged in urine 
resulting from maximal tubular reabsorption of the free drug. Its action gets 
prolonged in chronic renal failure. It undergoes high hepatic extraction, hence 
its clearance is sensitive to hepatic blood flow. 
Context sensitive half-time
It is less than that for alfentanyl. After termination of sufentanil infusion 
the  decrease  in  plasma  drug  concentration  is  accelerated  not  only  by 
metabolism  also  by  continued  distribution  to  the  peripheral  compartment. 
Compared to alfentanyl as a more favourable recovery profile when used for a 
longer period of time. 
Preparation
Sufentanil citrate equivalent to sufentanil 0.050 mg/ml.
Dosage
Analgesic dose:
I.V. (bolus) 0.3 to 2 mcg/kg
Epidural 15-30 mcg
Labor pain (I.V.) 10 mcg
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Clinical Uses
A single dose of sufentanil 0.1 to 0.4 mcg/kg I.V. produces a longer 
period of analgesia and less depression on ventilation than does a comparable 
dose of fentanyl 0.1 to 0.4 mcg/kg I.V. In large doses used for rapid induction 
of anaesthesia earlier emergence and earlier tracheal extubation.42 Like other 
opioids  it  decreases  the  cerebral  metabolic  oxygen  requirement  with 
bradycardic effect is sufficient to produce a decrease in cardiac output. 
Adverse effect 
As observed with fentanyl delayed depression on ventilation has been 
described. Large doses used for I.V. induction results in muscle rigidity making 
positive pressure ventilation difficult. Transient skeletal muscle spasm has been 
described  after  large  doses  (40  mcg)  of  accidental  intrathecal  injection 
suggesting a irritative effect of this drug.22
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REVIEW OF LITERATURE
Identification of opiate receptors in the brain and spinal cord and the 
role of morphinomimetic substances in the mechanisms of pain perception have 
led to the use of intrathecal opioid in animals and man for the relief of pain.
Intrathecal Opioids
Pert CB and Sinder SH [1973]34 demonstrated the presence of opioid 
receptors ion high density in the dorsal horn of the spinal cord.
Yaksh  TL  and  Rudy  TA  [1976]49 published  a  study  on  the 
effectiveness of intrathecal  morphine for relief of experimental pain in rats. 
This report initiated a series of trails in main.
Behar M et al [1979]4 reported the first effective use of epidural opioids 
in human while Wang JK et al [1979]45 reported the first controlled study of 
intrathecal opioids in human. They demonstrated that small doses of morphine 
given intrathecally or extradurally produced long lasting relief of chronic and 
post  operative  pain  in  man.  The  use  of  these  methods  spread  rapidly  and 
became  clinically  accepted  long  before  data  from  controlled  studies  were 
published.
Crawford JS [1980]10 claimed that spinal opioids act predominantly on 
the brain.
Willer  JC  and  Bussel  B48 [1980]  and  Maruyama  Y  et  al  [1980] 
suggested a selective spinal analgesic effect in humans. Willer JC and Bussel B 
[1980] and Yaksh TL [1981] suggested that  opioids act  on presynaptic and 
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postsynaptic receptors in the substantia gelatinosa of spinal cord dorsal where 
they inhibit neurone cell excitation.
Nicol et al [1991]32 studied densities of various drugs used intrathecally. 
They used 5% glucose as a vehicle for use as a hyperbaric solution along with 
opioids.  They  concluded  that  all  drugs  dissolved  in  5%  glucose  were 
hyperbaric in comparison with CSF at room and body temperature.
Complications
Glynn  CG  et  al [1979]16 and  Davies  GK  et  al  [1980]  reported 
respiratory depression following spinal morphine.
Glynn CG et al16 [1979] reported a respiratory depression with rostral 
spread of spinal opioids. He noted a delay of upto 11 hours before onset of 
respiratory depression following spinal morphine.
Jones RDM24  [1980] reported that naloxone was effective for reversing 
such respiratory depression without reversing analgesia.
Reiz and Westberg [1980] and Yaksh TL [1981] and Samii J, Chanin 
M and Viars P [1981] reported adverse reactions such as pruritus and urinary 
retention after intrathecal administration of opioids.
Oyama  T  [1980]33 observed  that  pruritus  did  not  occur  following 
intrathecal β-endorphin.
Bromage  PR  et  al  [1982]7 suggested  that  pruritus  may  be  due  to 
alterations in sensory modulations following opioid spread over the spinal cord 
to the brain. They also found naloxone to be effective in the control of pruritus 
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in some cases.
Roscow  CE  et  al  [1982]37 reported  pruritus  associated  with  spinal 
opioids but was a opinion that it was unlikely to be due to histamine release 
since pruritus occurred with fentanyl which does not cause systemic release of 
histamine.
Lam et al [1983]27 reported that delayed respiratory depression does not 
occur  after  epidural  fentanyl  which  has  lipophilic  properties  similar  to 
pethidine.
Cousins MJ and Mather LE  al [1984]8 suggested that the pruritus was 
unlikely to be due to the preservatives in the opioid since it occurs also with 
preservative free preparations.
Roxane Fournier38 et al in a study of on 42 geriatric patients scheduled 
for  elective  total  hip  replacement  surgery  where  randomized  and  double 
blinded.  One  group  received  7.5  μg  with  2  ml  of  hyperbaric  bupivacaine 
intrathecally  and other group received 40 μg fentanyl with 2 ml  hyperbaric 
bupivacaine on comparing between sufentanil  and fentanyl time to onset  of 
sensory block was 9 min vs. 11 min and the time to first systemic analgesic 
intervention was 241 vs. 214 min. He concluded that both lipid soluble opioids 
produced  excellent  analgesia  both  comparable  onset,  duration  and  low 
incidence of side effects. 
DeBalli P14  et al studied the synergesic effect of intrathecal opioids of 
combined  spinal  epidural  anaelgesia  during  labour.  They  observed  that  an 
intrathecally  administered  opioid  provides  rapid  onset  of  labour  analgesia 
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without motor block or significant haemodynamic pertubation. 
WC Lau  et  al28 in  his  randomized prospective  double  blinded study 
designed to examine post operative recovery with two anaesthetic techniques 
for  unilateral  ESWL  i.e.,  intrathecal  sufentanil  versus  intrathecal  5% 
lignocaine. Patients were randomized to receive either intrathecal sufentanil 20 
μg plus saline or intrathecal 5% lignocaine. Patients who received intrathecal 
sufentanil ambulated [79 min vs. 146 min], voided [80 min vs. 152 min] and 
were discharged home [98 min vs. 166 min] sooner than the other group.
BBEN David  et al5 showed the synergism between intrathecal opioids 
and local  anaesthetics  in  providing reliable  spinal  anaesthesia  with minimal 
hypertension. 20 patients aged more than 70 years undergoing surgical repair of 
hip fracture were randomized into two groups of 10 patients each. Group A 
received  bupivacaine  4  mg plus  fentanyl  20  μg.  Group  B  received  10  mg 
bupivacaine. All patients had satisfactory anaesthesia. One of the 10 patients in 
Group  A required  ephedrine.  9  of  the  10  patients  in  Group B required  an 
average 35 mg ephedrine and 2 patients required phenylpephrine, showing that 
mini-dose  combination  of  local  anaesthetic  opioid  cost  dramatically  less 
hypotension than large dose conventional local anaesthetics.
Herman  et  al19 compared  the  analgesic  and  untoward  effects  of 
intrathecal fentanyl versus sufentanil at equipotent doses for labor. 40 healthy 
pregnant  partiurients  were  recruited  for  the  study  after  randomization.  One 
group received 17.5 μg of fentanyl and other group received 9 μg of sufentanil. 
Pain was assisted with vast  scale,  in addition oxygen saturation,  respiratory 
ETCO2 analgesic success was 91% and 95% in the fentanyl group compared to 
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sufentanil. The analgesic duration with fentanyl and sufentanil was 76 min vs. 
101 min. Incidence of pruritis was more in the patients receiving sufentanil.
Jiri Malek et al22 studied the efficacy and safety of intrathecal fentanyl 
and  sufentanil  added to  bupivacaine  for  surgical  repair  for  hip  fractures  in 
patients  above  60  years.  After  standard  premedication  group  C  was 
administered 0.5% bupivacaine 3 ml with one ml saline. Group F 3 ml of 0.5% 
bupivacaine with fentanyl 50 μg and groups  bupivacaine 0.5% 3 ml with 5 
mcg  sufentanil.  Duration  of  analgesia  was  longer  in  both  opioid  groups 
compared to control [5.4 h] and longer in S [9.5 h] than in F [8.1 h]. There was 
no  difference  in  bradycardia,  hypotension,  oxygen  saturation  and  pruritis 
among the groups. Sufentanil appears to be more convenient because of longer 
analgesia and less post operative nausea and vomiting.
Ben David et al.5 studies the synergism between intrathecal opioids and 
local  anaesthetic  on  pain  relief  without  prolonging  recovery.  Fifty  patients 
undergoing ambulatory surgical arthroscopy were randomized into two groups 
receiving spinal anaesthesia with 3 ml of 0.17% bupivcaine [Group I] or with 
[Group II] the addition of 10 mg fentanyl. It was concluded that addition of 10 
μg Fentanyl to spinal anaesthesia with small dose bupivacaine intensified and 
increased the duration of sensory blockade without increasing the intensity of 
motor blockade or prolonging recovery to micturation or home readiness.
DW  Cooper  et  al9  studied  the  effect  of  intrathecal  dimorphine  or 
intrathecal fentanyl to supplement spinal anesthesia as post caesarean section 
analgesia.  50 patients  received 2 ml of bupivacaine  with 50 μg of  fentanyl 
versus 50 patients receiving dimorphine with bupivacaine. Final results showed 
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fentanyl group had good analgesia, better haemodynamic stability and lesser 
side effects.
Bogra  et al21 studied the synergistic effect of intrathecal fentanyl and 
bupivacaine in spinal anaesthesia. This study was performed on 120 caesearean 
section partiurients divided into six groups B8, B10, B12.5 receiving 8, 10, and 
12.5 mg of  bupivacine respectively and the groups FB8,  FB10 and FB12.5 
receiving the same dose of above but in combination with 12.5 μg fentanyl. On 
the onset of sensory block occurred faster in bupivacaine in fentanyl groups. 
Lower  concentrations  of  bupivacaine  alone  could  not  completely  remove 
visceral  pain.  It  was  concluded  bupivacaine  fentanyl  combination  leads  to 
abolishment of visceral pain increased haemodynamic stability and increased 
duration of post op analgesia.
Fauzio Bano  et al3 conducted a prospective randomized study on the 
role of intrathecal fentanyl as an adjunct to hyperbaric bupivacaine in spinal 
anaesthesia for caesaearan section. 60 young adult females undergoing elective 
and emergency LSCS where randomly allocated to receive spinal anaesthesia 
either  by  using 0.75% hyperbaric  bupivacaine  1.5 ml  with 0.25  ml  normal 
saline or 0.75% bupivacaine with 0.25 ml fentanyl. Comparing the bupivacaine 
group  time  to  achieve  highest  sensory  level  for  significant  shorter  in  the 
fentanyl  group while  the duration of  complete analgesia lasted significantly 
more longer in the fentanyl group than bupivacaine group [184 min vs. 126 
min].
Karim Asehounne25 et al conducted a prospective randomized study in 
patients undergoing lower abdominal and neurological surgeries under spinal 
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anesthesia.  Patients  received  5  μg  sufentanil  with  7.5  mg  of  hyperbaric 
bupivacaine.  They  recorded  cardiac  output  by  impedance,  cardiography, 
arterial blood pressure and heart rate. They demonstrated that sufentanil with 
low  dose  bupivacaine  provided  successful  anaesthesia  prolongation  of 
analgesia and better cardiac stability.
S K K Ngiam31 et al studied the effect of adding intrathecal sufentanil 
and fentanyl to bupivacaine in emergency LSCS. One group received 15 μg 
fentanyl added to 7.5 mg of bupivacaine and other received 10 μg of fentanyl 
with 7.5 mg of bupivacaine. They demonstrated increase in effective analgesia 
time with 358%  in sufentanyl group and 256% in fentanyl group. There was 
increased incidence of desaturation 45% versus 56% and pruritis 35% versus 
27.8% in the sufentanil group.
Anchalae  Techanivate2 et  al  assessed  the  effectiveness  of 
administration of fentanyl in spinal anaesthesia for appendisectomy. 40 patients 
randomized and double blind where recruited to receive either 4 ml of 0.5% of 
hyperbaric bupivacaine with 20 μg of fentanyl [Group F] for 4 ml of 0.5% 
hyperbaric bupivacaine with 0.4% normal saline [Group S]. The time to first 
requirement of post operative analgesia in Group F of significantly higher than 
in group S [13.6 vs.  6.3 hours].  There was no significant differences in the 
incidence of nausea, vomiting, hypotension and urinary retension.
Gupta18 et al studied the role of low dose bupivacaine plus fentanyl for 
intrathecally  during  ambulatory  inguinal  herrhaphy.  40  patients  randomly 
divided and double blinded into two groups. Group L received bupivacaine 6 
μg and group H bupivacaine 7.5 μg. In both the groups fentanyl 25 μg was 
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added to the spinal anaesthetic.  They concluded no difference in the spread 
duration and regression of sensory blocks between the groups.
Singh  Harbhej39 et  al.  showed  in  his  study  intrathecal  fentanyl 
prolonged sensory bupivacaine spinal block. Forty patients undergoing lower 
extremities or genitourinary surgery were enrolled to receive either 13.5 mg 
hyperbaric bupivacaine 0.75% with 0.5 ml is Sufentanil [Group I] or 13.5 mg 
hyperbaric bupivacaine 0.75% with 25 μg Fentanyl [Group G] according to a 
randomized assessor blind protocol. The onset and duration of sensory block 
onset  and  duration  of  motorblock  was  assessed.  The  time  required  for  two 
sensory segment regression and sensory regression to L1 dermatome was 74 ± 
18 and 110 ± 33min versus 93 ± 22 and 14 ± 37 min in  Groups I  and II 
respectively.They  concluded that  Fentanyl  25  μg prolonged the  duration  of 
bupivacaine  induced  sensory  block  by  28%  and  reduced  the  analgesic 
requirement in early postoperative period.
Goodzari M.17 et al studies the effect of large dose of intrathecal opioids 
on the autonomic nervous system. They compared two groups of patients aged 
10-16 years. Group one received intrathecal opioid. Group II [epidural group] 
received 0.5% bupivacaine intrathecal epidurally. The sympathetic effects of 
intrathecal opioid and epidural bupivacaine were monitored by the changes in 
toe relative to calf temperature and by the changes in pulse wave gradient with 
digital plethysmography. All patients demonstrated changes in their calf to the 
gradients after intrathecal and epidural  injection [-3.2 ± 1.6].  Systolic blood 
pressure decreased from a area of 70 ± 15 mm Hg to 55 ± 10 mm Hg. They 
concluded that the increases in pulse wave, amplitude and decreases in calf-toe 
gradients indicate a sympatholytic effect after intrathecal opioid similar to that 
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of local anaesthetics.
Martor J.W. et al. studied the synergism between intrathecal opioids 
and  local  anaesthetics.  They  studied  40  elderly  patients  having  either  an 
injection of a dynamic hip screw or a hemiarthroplasty and compared 9 mg 
glucose free bupivacaine with added fentanyl 20 μg [Group BF] and 11 mg 
glucose  free  bupivacaine  alone [Group B].  The incidence and frequency of 
hypotension in Group BF were less than in Group B. Similarly full in systolic, 
diastolic and mean blood pressure all less in Group BF than in Group B.
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MATERIALS AND METHODS
This  study  was  conducted  at  Government  General  Hospital,  Madras 
Medical College and Research Institute, Chennai – 600 003 between July 2006 
to August 2006 on 50 patients of ASA Physical Status I and II undergoing 
Inguinal and below Inguinal region surgeries. The study was done after getting 
institutional approval. Written informed consent was obtained from all patients 
included in the study.
Study  Design:  This  study  was  done  in  a  prospective  double  blind 
randomized manner. The patients were divided into two groups of twenty-five 
each .  Patient  meeting criteria  incorporated into study, randomly allotted to 
either group by draw of lots.
Group  F:  Patients  in  this  group  received  10  mg of  0.5% hyperbaric 
bupivacaine with 50 μg of Fentanyl added to a total volume of 3 ml.
Group  S:  Patients  in  this  group  received  2  ml  [10  mg]  of  0.5% 
hyperbaric bupivacaine with sufentanil 5 μg [diluted with 5% dextrose] and 
volume made to 3 ml.
The final volume of injected solutions was 3 ml in both the groups.
In the study 0.5% Bupivacaine in 8% dextrose manufactured by  SPM 
Drugs,  Fentanyl  citrate  [Free]  manufactured  by  PHARMACHEMICO 
laboratories, sufentanil manufactured by CORE HEALTH and the dilutent 5% 
dextrose prepared by IVES DRUG INDIA LTD was used.
All solutions were prepared under aseptic precaution by the operation 
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theatre  incharge  anaesthesiologist  uninvolved  in  the  administration  of 
subarachnoid block or in the observation of patients. 
The  specific  gravity  of  the  injected  solution  1.008  and  this  was 
hyperbaric related to cerebrospinal fluid [1.006].
Selection of Cases
Inclusion Criteria 
Male  and  female  patients  in  age  group  of  20-60  years  undergoing 
elective Inguinal and below Inguinal region surgeries. 
ASA I and II
Exclusion Criteria
Patient’s refusal
ASA physical status III, IV and V
Deformity of vertebral column
Neurological diseases
Local sepsis
Bleeding diathesis
Pre Anaesthesia Evaluation
History
Medical  illness,  previous  surgery,  anaesthetic  and  hospitalization, 
allergy to drugs and local anaesthetics.
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Physical examination: General condition
Vital signs
Height and weight
Examination of CVS, RS, CNS and vertebral column
Airway Assessment
Investigations
Complete hemogram
Blood sugar
Blood urea
Serum creatinine
Bleeding time and clothing time
Urine analysis
Chest X-ray
Electro cardiogram
Patients who satisified the inclusion critieria were explained about the 
nature of the study and anaesthetic procedure. Written informed consent was 
obtained from all patients included in the study.
All patients were reviewed the day prior to surgery. The VAS [visual 
analogue scale] was explained to the patient. The patients were shown a 10 cm 
long scale marked 0-10 a blank paper and told 0 represents no pain and 10 
represents worst possible pain. Patients were advised nil per oral 6 hours prior 
to surgery.
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Premedication
In the pre medication room, pulse rate, blood pressure, respiratory rate 
and oxygen saturation were noted. No sedative premedication was given as it 
would interfere with the observations. An intravenous line was started with a 
16  gauge  intravenous  canula  and pre  loading  done  with  10  ml/kg  of  0.9% 
normal saline over 30 minutes.
Technique
In the operating room appropriate equipment for airway management 
and  emergency  drugs  were  kept  ready.  Patients  were  shifted  from  the 
premedication room to the operation theatre.  The horizontal  position of the 
operating table was checked. The patients were made to be supine with a pillow 
under head. Non invasive BP monitor, pulse oximeter and electrocardiogram 
leads were connected to the patient. Preoperative baseline systolic and diastolic 
blood pressure;  pulse rate,  respiratory rate and O2 saturation were recorded. 
The  anaesthesiologist  unaware  of  the  drug  combination  performed  the  sub 
arachnoid block and made the observations in all the patients involved in the 
study.
Patients were placed in the right lateral position. Skin over the back was 
prepared with antiseptic solution and draped with a sterile towel. The L3-L4 
interspace  was  identified  and  23  G  Quicke-Babcock  spinal  needle  was 
introduced in this space through a midline approach. Once the needle pierced 
the dura and was in the sub arachnoid space, the stylet was removed. Free flow 
of  CSF  at  the  hub  of  the  needle  was  verified.  The  prepared  solution  was 
injected at a rate of 1 ml every 5 seconds without barbotage. The direction of 
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needle aperture was cephalad during drug administration. The total volume of 
injectate was 2 ml.  The patients  were made to be supine immediately after 
injection and the following parameters were observed.
Sensory Block
Assessed  by  loss  of  sharp  sensation  to  pin  prick  using  23  G sterile 
needle bilaterally.  The assessment was started immediately after turning the 
patient to supine position and continued every 20 seconds till loss of pin prick 
sensation at T12 level. Onset of sensory block was defined as the time taken 
from intrathecal injection to loss of pin prick sensation at T12 dermatome. At 
the 30 minute interval after SAB, the maximum dermatomal level of sensory 
block was noted. This was considered the maximum level of sensory block. 
Sensory block was checked every 15 min till 2 segment regression from the 
maximal level of sensory block occurred. The time to 2 segment regression was 
noted.  The  level  of  sensory  block  at  end  of  surgery  noted  and  thereafter 
assessment was carried out at 15 min intervals till return of pin prick sensation 
to  T12 dermatome.  Duration of  sensory block was taken as  time from sub 
arachnoid injection to return of pin prick sensation to T12.
Motor Block
Motor block was assessed bilaterally using modified Bromage scale.
Modified Bromage Scale
0 No block-able to raise extended leg against gravity
1 Unable raise extended leg but just able to flex knees
2 Unable to flex knee, but able to flex ankle
3 Total block-inability to flex ankle/move leg
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Assessment of motor block was started immediately after turning the 
patient supine. It was tested every 20 seconds till a Bromage scale of 1 was 
reached. Onset of Motor block was taken as the time to achieve Bromage score 
of 1 from time of subarachnoid injection. The degree of motor block 30 min 
after  intrathecal  injection  was  noted  and  was  considered  as  the  maximum 
degree of motor block. Thereafter motor block was assessed every 15 minutes 
until complete resolution of motor block [Bromage 0]. Duration of motor block 
was taken as time from sub arachnoid injection to return of Bromage score 0.
Vital signs
Blood pressure, Pulse rate, respiratory rate and oxygen saturation were 
recorded every 5 minutes throughout the intraoperative period. The above vital 
signs at the completion of surgery were noted.
Evaluation of side effects and complications
1. Respiratory depression
Respiratory depression was defined as a respiratory rate < 8/min and/or 
oxygen saturation ≤ 85 mm Hg. This was planned to be managed with bag and 
mask  ventilation  or  intubation  and  IPPV,  if  necessary.  Naloxone  0.1  mg 
intravenously administered every 5-10 min till  normal breathing pattern was 
established.
2. Nausea and vomiting
Patients were observed for nausea and vomiting. Vomiting was planned 
to be managed with Inj. Ondansetron 8 mg intravenously.
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3. Pruritus
Distressing pruritus was planned to be treated with Pheniramine maleate 
22.5 mg intravenously.
4. Hypotension
Hypotension was defined as systolic blood pressure <90 mm Hg or fall 
in  systolic  blood  pressure  >  30%  from  baseline.  This  was  planned  to  be 
managed with intravenous ephedrine in increments of 6 mg.
5. Bradycardia
Bradycardia was defined as a Heart rate less than 60 beats per minute 
and this was planned to be managed with Atropine 0.01 mg/kg intravenously.
6. Urinary retention
Post operative urinary retention was watched for and was planned to be 
managed by bladder catheterization.
7. Sedation
The  level  of  sedation  was  scored  according  to  the  six  grade  score 
devised by Ramsay and colleagues.
1 Anxious and agitated or restless or both
2 Co-operative, oriented, and tranquil
3 Responds to commands only
4 Asleep  with  brisk  response  to  light  glabellar  tap  or  loud  auditory 
stimulus
5 Asleep with sluggish response to stimulus
6 Asleep with no reponse to stimulus
A sedation score of greater than 4 was considered significant.
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Quality of surgical anaesthesia
Surgical anaesthesia was graded ‘Excellent’ if there was no complaint of 
pain from the patients at any time during surgery. ‘Good’ if there was minimal 
pain or discomfort which was relieved by a small dose of IV Pentazocine 0.25 
mg/kg and ‘Poor’ if general anaesthesia had to be administered.
Assessment in Post Anaesthesia Care Unit [PACU]
Patients were shifted to Post Anaesthesia Care unit after completion of 
surgery. The vital signs recorded every 15 minutes in the 1st hour after surgery 
and at 30 min intervals next two hours and thereafter every hourly for next 
three hours. Sensory and motor block assessments were done every 15 min till 
record of  pin prick toT12 and Bromage score 0 respectively.  Patients  were 
shifted to post operative ward after complete resolution of motor blockade.
Assessment of pain and duration of analgesia
At  the  end  of  surgery,  the  degree  of  pain  was  assessed  by  visual 
analogue scale [VAS]. In the PACU VAS was done every 15 minutes till VAS 
score  ≥  4  was  reached.  The  VAS  was  also  noted  whenever  the  patient 
complained of pain. Diclofenac sodium 75 mg was given intramuscularly, as 
the rescue analgesic. Duration of effective analgesia was defined as the time 
interval  between administration  of  sub  arachnoid  block  and  time to  reach  
VAS 4.
Patients  were  monitored  for  24  hrs  to  detect  the  occurrence  of  side 
effects  like  respiratory  depression,  nausea,  vomiting,  pruritus  and  urinary 
retention.
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Study material
A total of 25 cases each were randomly allocated to one of the following 
two groups of  study viz.  Group F -  Fentanyl  with Bupivacaine,  Group S - 
Sufentanil with Bupivacaine.
Statistical method
The descriptive statistics of the variables studied are represented as two-
way  tables.  The  categorical  factors  are  represented  by  the  number  and 
frequency (%) of cases. The continuous variables are represented by measures 
of central frequency (like mean, median & mode) and deviation (say, standard 
deviation and range). The differences in the proportions are tested for statistical 
significance using non-parametric Chi-Square test for variables measured on 
nominal  scale.  Fisher's  exact  probability  test  is  employed  whenever  the 
expected frequencies were very small. For variables measured on a continuous 
scale, when testing for two groups,  Student "t" test is used to test for statistical 
significance in the differences of the two means. Box plots are drawn to depict 
the summary statistics of continuous variables measured at a fixed one point in 
time. For continuous variables measured at different time points, line graphs 
are drawn to illustrate the trend of mean values at the respective time points. 
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OBSERVATION AND RESULTS
The study was  conducted at  Government  General  Hospital,  Chennai. 
Fifty patients were included in this double blind randomized control study.
The patients were divided into two groups of twenty five each patients 
in Group F received intrathecal bupivacaine 0.5%.10 mg [2 ml] with 50 μg [1 
ml] fentanyl. Group S patients received bupivacaine 0.5%. [2 ml] long with 5 
μg sufentanil. Volume of injectate was 3 ml in both the groups.
Demographic Data:
Both  the  groups  were  comparable  with  respect  to  their  age,  height, 
weight, baseline pulse rate, systolic and diastolic blood pressure, respiratory 
rate and oxygen saturation. The duration of surgery was also comparable in the 
two groups. There was no statistically significant difference among the two 
groups in demographic aspect.  
Table 1: Distribution of age of cases by groups$
Age Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
30.2
6.38
30
30
20-45
25
28.5
5.73
28
25
21-45
0.33
$ Not statistically significant
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The mean age was observed to be slightly higher in Group F than Group 
S but not statistically significant.
Table 2: Distribution of height of cases by groups$
Height Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
163.7
5.18
165
165
161-170
25
163.8
3.71
165
165
160-170
0.95
       $ Not statistically significant
The mean height was observed to be almost the same in Group F than 
Group S and not statistically significant.
Table 3: Distribution of weight of cases by groups$
Weight Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
58.7
5.31
58
52
51-70
25
58.2
4.69
57
57
51-69
0.72
       $ Not statistically significant
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The  distribution  of  cases  by  weight  and  the  difference  in  the  mean 
values  are  observed to be not  statistically  significant between Group F and 
Group S. 
Block Characteristics
Onset of sensory block: The time taken to achieve a level of T12 from the 
time  of  administration  of  subarachnoid  block  was  tested  bilaterally  by  pin 
prick. The mean time taken for onset in Group F was 9.04 min and in Group S 
was 7.4 min. Statistically significant difference was observed in the onset of 
sensory block.
Table 4: Distribution of onset of sensory block by groups*
Time of onset of 
sensory block Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
9.04
2.03
9.0
8.0
5-12
25
7.4
2.16
7
5
4-12
0.008
     * Statistically significant
The mean time of onset of sensory block age was observed to be higher 
in Group F than Group S and is statistically significant.
Maximum level of sensory block
The range of maximum level of sensory block in Group F was T4-T8 
with a  maximum at  T5 [52%].  The range in  Group S was also T4-T8 and 
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maximum at T6 [40%]. The distribution of patients in each level of maximum 
sensory block is shown in.
Table 5: Distribution of maximal height of sensory block by groups$
Attempt Gr. F (25) Gr. S (25)
No. % No. %
p-value
T4
T5
T6
T7
T8
4
13
4
2
2
16.0
52.0
16.0
8.0
8.0
6
6
10
1
2
24.0
24.0
40.0
4.0
8.0
0.21
       $ Not statistically significant
Time to two segment regression 
The time to  two segment  regression in  Group F was 39 min and in 
Groups was 42.2 mins which was not statistically significant.
Table 6: Distribution of two segmental regression values by groups$
Two segmental 
regression Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
25
39.8
13.96
40
20
25
42.2
15.95
40
40
0.57
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Range 20-65 20-85
       $Not Statistically significant
The mean duration of two segmental regression values was observed to 
be higher in Group S than Group F but not statistically significant.
Duration of sensory block [surgical anaesthesia]
Duration of surgical anaesthesia in Group F was 142.8 min [mean] and 
the duration in Group S was 137.6 min [mean]. Though the mean duration of 
surgical anaesthesia was observed to be higher in Group F than Group S, but it 
was not statistically significant .
Table 7: Distribution of duration of surgical anaesthesia of cases by 
groups$
Duration of surgical 
anaesth Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
142.8
26.30
150
150
90-180
25
137.6
19.43
135
135
105-180
0.43
       $ Not statistically significant
The mean duration of surgical anaesthesia was observed to be higher in 
Group F than Group S but not statistically significant.
Quality of Surgical Anesthesia 
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Quality of Surgical anaesthesia was graded excellent in all but 2 patients 
one belonging to Group F and other to Group S, where the quality was rated 
good and had to be supplemented by narcotics.
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Duration of effective analgesia
The mean duration of effective analgesia defined as the time to reach 
VAS score ≥ 4 from the time of subarachnoid block was 216.8 min in Group F 
and 264.6 min in Group S. This was statistically significant among the groups.
Table 8: Distribution of duration of post operative anaesthesia of cases by 
groups*
Duration of post op 
anaesthesia Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
216.8
46.16
210
200
120-340
25
264.6
29.89
275
280
195-300
<0.001
    * Statistically significant
The mean duration of post operative anaesthesia was observed to be 
higher in Group S than Group F and is statistically significant
Maximum grade of motor block
The maximum degrees of motor block in Group F ranged between B2-
B4 with maximum at B3 [60%]. In groups the range was between B1-B4 and 
maximum  at  B3  [60%].  This  was  not  statistically  significant  between  the 
groups.  
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Table 9: Distribution of maximal grade of motor block by groups$
Attempt Gr. F (25) Gr. S (25)
No. % No. %
p-value
B1
B2
B3
B4
0
4
15
6
0.0
16.0
60.0
24.0
1
8
15
1
4.0
32.0
60.0
4.0
0.11
        $ Not statistically significant
Duration of motor block
The duration was read when bromage scale referred to BO. The mean 
duration of motor block in Group F was 131.6 min while it was 90.8 min in 
Group S which was statistically significant.
Table 10: Distribution of duration of motor block by groups*
Duration of 
motor block Gr. F Gr. S p-value
No. of cases
Mean
S.D.
Median
Mode
Range
25
131.6
17.84
130
130
90-180
25
90.8
15.12
90
80
60-120
<0.001
     * Statistically significant
The mean duration of motor block was observed to be higher in Group F 
than Group S and is statistically significant.
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Haemodynamic parameters
Heart rate
The distribution of cases by heart rate and mean values were observed to 
be  generally  not  statistically  significant  between the  Group F and Group S 
when all times are taken together and at all the different time points both intra 
and post operatively.  
Table 11: Mean Distribution of cases by groups and HR$
HR Gr. F
(n=25)
Gr. S
(n=25) p-value
Intra OP time (0-60) - Average
Mean
SD
80.5
10.93
79.0
6.42
0.55$
Intra OP time 0
Mean
SD
84.8
13.48
80.4
11.51
0.22
Intra OP time 15
Mean
SD
76.3
13.45
76.6
9.84
0.94
Intra OP time 30
Mean
SD
75.1
12.97
77.3
8.35
0.49
Intra OP time 45
Mean
SD
75.5
12.82
76.2
7.74
0.83
Intra OP time 60
Mean
SD
73.7
10.92
76.3
7.38
0.33
Post OP time (0-60) - Average
Mean
SD
77.6
7.74
78.1
4.55
0.78$
Post OP time 0
Mean
SD
77.3
9.86
77.0
6.61
0.90
Post OP time 15
Mean
SD
78.3
9.86
78.0
7.94
0.91
Post OP time 30
Mean
SD
76.4
8.35
79.4
7.25
0.19
Post OP time 45
Mean
SD
78.3
7.97
77.8
5.55
0.79
Post OP time 60
Mean
SD
77.6
6.30
78.3
5.72
0.67
$ Not statistically significant
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Systolic blood pressure
The distribution of cases and mean value of systolic blood pressure were 
observed  to  be  generally  not  statistically  significant  between  Group  F  and 
Group S at all time points taken together and at every different time patients 
both intra and post operatively.
Table 12: Distribution of cases by groups and systolic blood pressure$
Systolic blood pressure Gr. F
(n=25)
Gr. S
(n=25) p-value
Intra OP time (0-60) - Average
Mean
SD
125.4
10.75
128.5
15.56
0.41$
Intra OP time 0
Mean
SD
128.0
13.33
133.7
20.93
0.26
Intra OP time 15
Mean
SD
125.1
16.19
120.1
19.41
0.33
Intra OP time 30
Mean
SD
123.2
15.57
125.7
19.23
0.62
Intra OP time 45
Mean
SD
124.0
16.02
126.8
17.84
0.56
Intra OP time 60
Mean
SD
123.4
14.80
127.4
17.89
0.40
Post OP time (0-60) - Average
Mean
SD
123.4
7.57
127.7
14.67
0.20$
Post OP time 0
Mean
SD
124.1
12.09
126.4
20.63
0.63
Post OP time 15
Mean
SD
126.2
12.9
129.4
20.02
0.51
Post OP time 30
Mean
SD
124.0
13.03
126.3
20.68
0.64
Post OP time 45
Mean
SD
122.5
10.01
128.7
19.65
0.16
Post OP time 60
Mean
SD
120.2
8.02
127.8
18.39
0.07
$ Not statistically significant
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Diastolic blood pressure
The distribution of cases and the mean values of diastolic blood pressure 
were observed to be generally not statistically significant between Group F and 
Group S when all time points are taken together and at all the different time 
points postoperatively with the exception of time points 15 min and 60 min 
intra operatively.
Table 13: Distribution of cases by groups and diastolic blood pressure$
Diastolic blood pressure Gr. F
(n=25)
Gr. S
(n=25) p-value
Intra OP time (0-60) - Average
Mean
SD
76.6
6.19
79.7
6.89
0.10$
Intra OP time 0
Mean
SD
78.9
9.07
81.0
7.83
0.39
Intra OP time 15
Mean
SD
73.0
10.50
80.5
13.07
0.03*
Intra OP time 30
Mean
SD
75.5
8.33
78.6
13.30
0.33
Intra OP time 45
Mean
SD
74.8
7.77
77.8
11.79
0.29
Intra OP time 60
Mean
SD
73.5
7.18
79.4
11.21
0.03*
Post OP time (0-60) - Average
Mean
SD
94.6
6.63
97.5
6.35
0.12$
Post OP time 0
Mean
SD
79.0
10.08
81.4
8.34
0.37
Post OP time 15
Mean
SD
84.1
9.73
82.7
9.29
0.59
Post OP time 30
Mean
SD
77.9
13.12
82.2
8.07
0.16
Post OP time 45
Mean
SD
77.5
7.08
81.0
5.91
0.07
Post OP time 60
Mean
SD
77.7
6.67
80.5
5.82
0.13
$ Not statistically significant; * p≤0.05
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Side effects and complication
The incidence of hypotension was 8% in Group F and 16% in Group S.
The incidence of bradycardia was 12% in Group F and 20% in Group S.
The incidence of pruritis was 40% in Group F and 48% in Group S.
The incidence of nausea was 4% in each of the groups.
There seems to be no significant difference in the distribution of cases 
by bradycardia,  hypotension, nausea and pruritis.  None of the cases in both 
experienced  the  following  condition  like  respiratory  depression,  sedation, 
vomiting, urinary rentention or neurological complication.
Table 14: Distribution of cases by groups and complications$
Co-morbid 
conditions
Gr. F Gr. S
No. % No. %
p-value
Bradycardia
   Yes
   No
3
22
12.0
88.0
5
20
20.0
80.0
0.70
Hypotension
   Yes
    No
2
23
8.0
92.0
4
21
16.0
84.0
0.67
Nausea
    Yes
    No
1
24
4.0
96.0
1
24
4.0
96.0
1.00
Pruritis
    Yes
    No
10
15
40.0
60.0
12
13
48.0
52.0
0.57
     $ not statistically significant
There seems to be no significant difference in the distribution of cases 
by Bradycardia, hypotension, Nausea and Pruritis. None of the cases in both 
experienced  the  following  conditions:  Respiratory  Depression,  sedation, 
vomiting, urinary retention and others.
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DISCUSSION
The intrathecal injection of opioids combined with local anaesthetics at 
lower than conventional doses provides effective central neuroxial block with 
satisfactory analgesia and adequate relaxation for surgeries of inguinal region. 
The  adding  of  opioids  to  local  anaesthetics  had  an  added  advantage  of 
prolonged post op ambulation with earlier mobilization due to shorter duration 
of motor blockade. It is now apparent that with attention to patient selection, 
appropriate  choice  of  drugs,  dosage,  route  of  administration  and  adequate 
patient  monitoring,  the  benefits  of  intra  spinal  local  anaesthetic  opioid 
combination can be obtained with a high degree of safety.
The study was designed to compare and contrast the combination of a 
local anaesthetic at lower than conventional doses with two different opioids 
administered intrathecally with regards to their efficacy and safety. A total of 
fifty patients belonging to ASAI physical status within the age group 20-50 
years scheduled to undergo surgeries of inguinal region were taken up for the 
study. Patients belonging to Group F [fentanyl group] received 2 ml of 0.5% 
Bupivacaine with 50 μg Fentanyl (1 ml) intrathecally. Other Group (Group S – 
Sufentanil group) received 2 ml of 0.5% Bupivacaine with 5 μg of Sufentanil. 
Both the groups were closely observed for the pattern of block characteristics 
and hemodynamic stability. The quality of analgesia, pattern and duration of 
motor blockade was studied. For assessing hemodynamic stability, parameters 
such as heart rate, systolic and diastolic blood pressure was recorded at specific 
intervals both intra op and post-operatively. The occurrence of any side effects 
such as nausea, vomiting, respiratory depression, sedation; pruritis and urinary 
retention was also analysed.
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Quality  of  Analgesia: The  onset  time  to  sensory  block,  two  segment 
regression  duration  of  surgical  anaesthesia  and  post  op  analgesia  were 
documented and statistical significance derived.
With  regards  to  sensory  block,  onset  time  was  much  quicker  in  the 
Sufentanil  Group S group with  a  mean of  7.4  mins  when compared to  the 
Fentanyl  group (Group F)  which recorded 9.04 min which was statistically 
significant. The time to two segment regression was comparable between the 
groups.  Even  though  there  was  a  mild  variation,  it  was  not  statistically 
significant.
ROXANE  et  al.38 compared  the  use  of  intrathecal  analgesia  with 
Fentanyl and Sufentanil in geriatic patients undergoing total hip replacement 
under  spinal  anaesthesia.  In  his  study  onset  time  to  sensory  block  was 
comparable with Fentanyl having a onset time of 11 ± 8 min and Sufentanil 9 ± 
8 min which is supportive to our finding.
GOEL et al in his study for day case surgery observed the time to two 
segment regression and S2 regression and with Fentanyl it  was significantly 
longer than Sufentanil.
SINGH HARBHEJ  et  al39 studied the  effect  of  intrathecal  Fentanyl 
when used with hyperbaric bupivacaine in spinal block in adult male patients. 
The time to 2 segment regression and sensory regression to L1 dermatone was 
93 ± 22 min and 141 ± 37 min.
In  regards  to  the  duration  of  surgical  anaesthesia,  there  was  not 
statistically  significant  difference  between the  two group and it  was  in  the 
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comparable  range  of  137-143  min.  In  our  study  with  equipotent  doses  of 
Fentanyl  and  Sufentanil,  the  duration  of  postoperative  analgesia  was  much 
longer in the Sufentanil group (216.8 vs. 264.6 min).
ROXANE et al38 in his study found that duration of action of intrathecal 
Fentanyl was 214 ± 120 min and that of Sufentanil 240 ±102 min. His findings 
are comparable to the findings of our study.
NORMAN L HERMAN19 in  his  study  on  labor  patients,  analgesic 
duration with intrathecal Fentanyl and Sufentanil was 76 ± 33 min and 101 ± 
58 min respectively. This study also shows the prolonged analgesic effect of 
Sufentanil.
Motor Blockade: With  regards  to  motor  block  number  of  patients  in  both 
group  exhibiting  maximal  grade  of  motor  block  (B4)  was  not  statistically 
significant. The significant finding in our study was the difference in duration 
of motor blockade between the two groups. The Group S had a much longer 
duration  of  motor  block  than  groups  establishing  a  slight  advantage  of 
Sufentanil over Fentanyl.
JOHN H STROGER et al23 reported use of intrathecal lignocaine with 
Sufentanil  for  shorter  post  op recovery  for  outpatient  rectal  surgery.  In  his 
study there  was a  significant  shorter  ambulation time (120 ± 26 min)  after 
intrathecal low dose lignocaine with 10 μg Sufentanil compared to 50 mg of 
intrathecal lignocaine alone (102 ± 32 min).
WE LAU et al21 reported earlier discharge of patients undergoing extra 
corporeal  shock  wave  lithotripsy  following  intrathecal  sufentanil  –  local 
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anaesthetic combination administered intrathecal.
With regards to hemodynamic stability between the two groups there 
was not statistical significant variation in systolic, diastolic blood pressure and 
heart rate. Even though the number of cases reporting hypotension in Group S 
was 4 compared to 2 in Group F, it was not statistically significant.
KARIM ASHEHOUNE et al25 in his study showed that small dose of 
Bupivacaine with Sufentanil administered intrathecally prevented the cardiac 
output  modification  in  patients  undergoing  elective  urological,  lower 
abdominal and lower limb surgeries when compared to large dose conventional 
Bupivacaine.
B BEN DAVID  et al5 reported synergism between intrathecal opioids 
and local anaesthetics and with this combination it may be possible to achieve 
reliable spinal anaesthesia with minimal hypotension.
GOODZARI et al17 reported in his study that there were cases showing 
decrease in blood pressure after spinal injection of opioids and this may be due 
to the sympatholytic effect of opioids similar to that of local anaesthetic drugs. 
This  finding  could  account  for  some  of  the  cases  in  our  study  developing 
hypotension requiring the use of vasopressors.
With regards to side effects, it is significant to note that there was no 
incidence of early or delayed respiratory depression (or) urinary retention in 
any of the patients involved in the study. Pruritis was the only significant side 
effect having almost an equal representation in both the groups. It responded 
well  to  antihistamine  and  reassurance.  One  patient  in  each  of  the  group 
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complained of nausea. No case in either of the groups had vomiting. 
BROMAGE PR  et  al  [1982]7 suggested that pruritus may be due to 
alterations in sensory modulations following opioid spread over the spinal cord 
to the brain. They also found naloxone to be effective in the control of pruritus 
in some cases.
ROSCOW CE  et  al37 [1982] reported pruritis  associated with spinal 
opioids but was a opinion that it was unlikely to be due to histamine release 
since pruritus occurred with fentanyl which does not cause systemic release of 
histamine.
WL  LOCK  et  al  described  cases  of  pruritus  in  patients  receiving 
combined spinal  epidural  for  labor  analgesia  who  had  received  fentanyl  or 
sufentanil but not in patients who were administered plain bupivacaine.
It  can  be  concluded  from  our  study  that  intrathecal  opioids  when 
administered with local anaesthetics in subarachnoid space is quiet safe. It has 
also been shown that by adding opioids to local anaesthetics intrathecally, the 
dose of the local anaesthetic can be substantially reduced and hence its side 
effects like excessive hypotension or bradycardia. With vigilant intra op and 
post  op  patient  monitoring  in  place,  intrathecal  low  dose  local  anaesthetic 
opioid combination appears superior to plain local anaesthetic alone. Among 
the two opioids Sufentanil appears to be more patient friendly with regards to 
its analgesic duration and early ambulation excepting for its cost.
SUMMARY
This double blind prospective randomized control study was designed to 
evaluate the efficacy and safety of low dose bupivacaine in combinations with 
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fentanyl  and  sufentanil  with  regards  to  hemodynamic  stability  and  block 
characteristics.
A total of fifty patients belonging to ASA physical status I belonging to 
age group between 20-50 years scheduled for inguinal surgeries were divided 
into two group.  The patients  in group F received 2 ml of 0.5% hyperbaric 
bupivacaine  with 50 μg [1 ml]  of  fentanyl  [total  volume of  3  ml].  The 25 
patients in Group S received 1 ml of 5 μg sufentanil [diluted with 5% dextrose] 
with 2 ml of 0.5% hyperbaric bupivacaine.
Time to onset and duration of sensory and motor block and the maximal 
dexmatome level of sensory block wave observed and noted. Post operatively 
the duration of analgesia was noted. During intra operative and post operative 
periods  hemodynamic  stability  was  assessed  with  recording  of  heart  rate, 
systolic  blood  pressure  and  diastolic  blood  pressure  at  specified  intervals. 
Special attention was paid to detect any side effects in either of the groups.
Following observation were made:
1. Intrathecal opioids [either Fentanyl or sufentanil] in combination with low 
doses  of  local  anaesthetic  [10  mg  of  0.5%  bupivacaine]  produced 
satisfactory sensory block of the lower abdomen.
2. The  onset  of  sensory  block  was  little  earlier  when  bupivacaine  was 
combined with sufentanil [7.4 min] than fentanyl [9.04 min].
3. The mean duration of sensory block was almost the same when bupivacaine 
was either combined with fentanyl [142.8 min] or sufentanil [137.8 min].
4. The mean duration of analgesia was significantly longer with bupivacaine 
combined with sufentanil [264.6 min] than with fentanyl 216.8.
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5. The  mean  duration  of  motor  block  was  shorter  with  sufentanil  in 
combination  with  bupivacaine  [90.8  min]  than  fentanyl-bupivacaine 
combination [131.6 min].
6. The  variation  of  heart  rate,  systolic  blood  pressure  and  diastolic  blood 
pressure  from  the  baseline  in  both  the  groups  was  not  statistically 
significant establishing a hemodynamic stability of intrathecal opioid low 
dose local anaesthetic combination than intrathecal local anaesthetic alone.
7. The incidence of side effects was relatively low with both the combination 
with only pruritis emerging as the leading complication in the either of the 
groups.
8. The percentage of cases reporting nausea, vomiting was very few in either 
of the groups.
9. None of the cases in either of the groups was complicated by respiratory 
depression, sedation and urinary retention.
10. No neurological complication were observed in any of the patients.
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CONCLUSION
This study confirms the safety and efficacy of intrathecal low dose local 
anaesthetic  opioid  combination  in  patients  undergoing  surgeries  of  inguinal 
region region of intermediate duration.
When  compared  to  intrathecal  bupivacaine  fentanyl  combination; 
intrathecal  bupivacaine  sufentanil  combination  provided  prolonged  post 
operative  analgesia  with  a  lesser  duration  of  motor  blockade  thus  allowing 
early post operative ambulation. Both the groups were comparable with regards 
to  haemodynamic  stability.  The  side  effects  of  intrathecal  opioids  are  not 
significant and can be easily managed. 
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PROFORMA
COMPARATIVE EVALUATION OF SUBARACHNOID BLOCK WITH LOW DOSE 
BUPIVACAINE AND FENTANYL VS. LOW DOSE BUPIVACAINE AND SUFENTANIL IN 
PATIENTS UNDERGOING INGUINAL SURGERIES
Name: Age: Sex:
Height: Weight: Unit:
I.P.No.:
Diagnosis:
Surgical Procedure:
Pre-Anaesthetic Evaluation:
a. History:
b. Clinical Examination:
General Examination:
CVS: CNS:
RS: Spine:
Vital Signs
BP (mmHg): Pulse rate: Respiratory rate:
Airway:
c. Investigations:
Urine analysis
Complete Hemogram
Blood Sugar
Blood Urea
Serum creatinine
Bleeding time
Clotting time
Chest X-ray
Electrocardiogram
ASA Physical Status:
Pre-operative vital signs
Pulse rate: Respiratory rate:
B.P.: Oxygen saturation:
Premedication:
Preloading:
Baseline vital signs
B.P.: Respiratory rate:
Pulse rate: Oxygen saturation:
Position in which subarachnoid block done:
Interspace chosen for subarachnoid block:
Size of spinal needle:
Modified Bromage Scale
0 No block-able to raise extended leg against gravity
1 Unable raise extended leg but just able to flex knees
2 Unable to flex knee, but able to flex hip
3 Total block-inability to flex ankle/move leg
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Block Characteristics:
Height of block (intra-operative):
1 
min
5 
min
10 
min
15 
min
30 
min
45 
min
60 
min
75 
min
90 
min
105 
min
120 
min
Levels
Sensory
Motor
Drug Dosage:
Time to sensory block T10:
Time to motor block (Gr 1 Bromage):
Maximum levels of sensory block:
Maximum degree of motor block:
Time to 2 segment regression (assessed every 15 minutes):
Intraoperative monitoring
Time 
(min)
0 
mi
n
1 
mi
n
2 
mi
n
3 
mi
n
4 
mi
n
5 
mi
n
10 
mi
n
15 
mi
n
30 
mi
n
45 
mi
n
60 
mi
n
75 
mi
n
90 
mi
n
10
5 
min
12
0 
min
13
5 
min
150 
min
PR
BP
RR
SpO2
Intraoperative side effects:
Treatment given:
Hypotension Y/N Pruitis Y/N
Bradycardia Y/N Rigors Y/N
Respiratory depression Y/N Others Y/N
Nausea and vomiting Y/N
Sedation Y/N
Duration of surgery:
Total amount of intravenous fluids given:
Total amount of blood given:
Intraoperative urine output:
Level of sensory block at end of surgery:
Degree of motor block at end of surgery:
VAS Score at end of surgery:
Postoperative vital signs:
1st hour 2nd hour 3rd hour 4th hour 5th hour 6th 
hour
0 15 30 45 60 90 120 150 180 240 300 360
BP
PR
RR
SpO2
Duration of motor blockade
Duration of sensory blockade Assessed every 15 minutes
Side effects in post operative period:
Treatment given
Hypotension Y/N Sedation Y/N
Bradycardia Y/N Pruitis Y/N
Respiratory depression Y/N Rigors Y/N
Nausea and vomiting Y/N Others Y/N
Post operative analgesia (VAS measured every 15 minutes):
Duration of effective analgesia:
Time of administration of rescue analgesia:
Postoperative urine output:
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